4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-012039
Director acquired 46,296 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hayden Michael R · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-16 | Exercise or conversion : show line 1 in the form | +5,144 | $2.68 | $13,786 | 112,706 | D |
| 2021-02-18 | Exercise or conversion : show line 2 in the form | +10,288 | $3.67 | $37,757 | 61,212 | I |
| 2021-02-18 | Exercise or conversion : show line 3 in the form | +30,864 | $2.68 | $82,716 | 92,076 | I |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-16 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −5,144 | 0 | D |
| 2021-02-18 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −10,288 | 0 | I |
| 2021-02-18 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −30,864 | 0 | I |
Loading xslF345X03/doc4.xml…